Company Overview
| Stock Name | Human Health |
|---|---|
| Stock Code | 01419 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 香港私營綜合醫療服務營運商,提供全科醫療、專科醫療及牙科服務,擁有66間醫務中心網絡。 |
| Listing Date | 2016-04-01 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港九龍九龍灣常悅道3號企業廣場2期12樓 |
| Business Address (Hong Kong) | 香港九龍尖沙咀柯士甸道45–53號聯業大廈11樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | humanhealth.com.hk |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 1.38 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.01 / shares |
| Offer Period | 2016-03-17 to 2016-03-22 |
| Global Offering Shares | 76,680,000 shares |
| HK Public Offer Shares (Initial) | 7,668,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 69,012,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 350,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 7.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 105,818,400 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 292.9M |
| Est. Threshold | HK$ 9.73B |
| Analysis Result | HK market cap below threshold, need +3221% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利约35.7百万港元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
HKD
Income Statement
| Item | 2013-06 | 2014-06 | 2015-06 | 2015-09 |
|---|---|---|---|---|
| Revenue | 333,933 | 365,246 | 429,538 | 110,786 |
| Cost of sales | -181,740 | -191,527 | -230,293 | -59,415 |
| Gross profit | 152,193 | 173,719 | 199,245 | 51,371 |
| Other income and gains, net | 2,475 | 580 | 1,815 | 427 |
| Administrative expenses | -111,035 | -124,938 | -155,879 | -45,334 |
| Share of associates and JVs | 0 | 0 | 0 | -37 |
| Profit before tax | 43,633 | 49,361 | 45,181 | 6,427 |
| Income tax expense | -7,005 | -8,604 | -9,463 | -1,858 |
| Profit for the year | 36,628 | 40,757 | 35,718 | 4,569 |
| Profit attributable to owners | 34,093 | 38,748 | 33,727 | 4,569 |
Balance Sheet
| Item | 2013-06 | 2014-06 | 2015-06 | 2015-09 |
|---|---|---|---|---|
| Cash and cash equivalents | 88,326 | 91,416 | 109,248 | 96,578 |
| Trade and bills receivables | 21,424 | 24,841 | 31,888 | 30,359 |
| Inventories | 3,667 | 4,797 | 7,295 | 6,729 |
| Total current assets | 121,146 | 131,862 | 164,311 | 154,951 |
| Total assets | 142,267 | 154,130 | 231,920 | 226,823 |
| Total current liabilities | 48,364 | 56,003 | 114,138 | 104,458 |
| Total liabilities | 48,496 | 56,082 | 116,921 | 107,255 |
| Total equity | 93,771 | 98,048 | 114,999 | 119,568 |
| Equity attributable to owners | 85,609 | 88,304 | 114,999 | 119,568 |
Cash Flow Statement
| Item | 2013-06 | 2014-06 | 2015-06 | 2015-09 |
|---|---|---|---|---|
| Net cash from operating activities | 38,970 | 41,346 | 55,235 | -3,470 |
| Net cash from investing activities | -5,798 | -6,956 | -31,903 | -4,205 |
| Net cash from financing activities | -18,329 | -31,300 | -5,500 | -4,995 |
| Net increase in cash | 14,843 | 3,090 | 17,832 | -12,670 |
| Depreciation of PP&E | 6,155 | 5,936 | 6,082 | 1,645 |
| Amortisation of intangible assets | 0 | 0 | 722 | 403 |
| Purchase of PP&E | -5,586 | -7,284 | -5,682 | -605 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 1.99 |
|---|---|
| First Day Open | HK$ 1.85 |
| First Day Change | 44.20% |
| First Day Volume | 180834000.0 |
| First Day Turnover | 361008000.0 |
| Use of Proceeds | 1、約31.5百萬港元(相當于所得款項凈額的46.0%)將用于為在香港透過設立六間新專科醫務中心以擴充本集團的醫務中心網絡提供部分資金;
2、約4.8百萬港元(相當于所得款項凈額的7.0%)將用于為在香港透過設立六間新全科醫務中心擴充本集團的醫務中心網絡提供部分資金;
3、約10.3百萬港元(相當于所得款項凈額的15.0%)將用于為本集團擴充至中國市場提供部分資金;
4、約6.9百萬港元(相當于所得款項凈額的10.0%)將用于在香港收購已設立的醫務中心;
5、約4.1百萬港元(相當于所得款項凈額的6.0%)將用于在香港透過聘請品牌顧問、進行品牌建設活動及翻新及維護我們現有醫務中心以提升我們的品牌形象;
6、約4.1百萬港元(相當于所得款項凈額的6.0%)將用于提升我們的信息科技基建設施;
7、約6.9百萬港元(相當于所得款項凈額的10.0%)將用于營運資金及其他一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
BOCOM International (Asia) Limited CE API271
Overall Coordinators (1)
交银国际证券有限公司 CE APJ121
Joint Bookrunners (2)
Joint Lead Managers (4)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 首都医疗国际有限公司 | 34,011,480 HKD | — | 7.04% | — | 6 months | 2016-10-01 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 陳健平 | — |
| Company Secretary | 薩翠雲 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Treasure Group、陳先生及彭醫生為控股股東,合共持有本公司72.10%權益。 |
|---|




